Decision Making for Older Patients with High-Risk MDS

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: April 30, 2014
Expiration Date: April 30, 2015

Expected time to complete this activity as designed: 30 minutes
There are no fees for participating in or receiving credit for this online activity.

Program Overview

One of the most essential skill sets for community oncology physicians and their multidisciplinary care team members who care for myelodysplastic syndrome (MDS) patients is navigating the diagnosis, staging, risk-stratification, and prognosis of this disease in order to develop appropriate treatment and management plans.

Target Audience

This activity is designed for physicians, physician assistants, and other health care professionals who have an interest in enhancing their clinical skills in treating elderly patients with MDS.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Demonstrate the differential diagnoses of older patients with high-risk MDS, including appropriate assessment and workup test and use of the International Prognostic Staging System
  • Formulate a tailored treatment plan which considers individual patient needs and treatment goals and clinical guideline recommendations for a high-risk elderly MDS patient

Agenda

Decision Making for Older Patients with High-Risk MDS – Jaroslaw Maciejewski, MD, PhD

Instructions for Participation and Credit

This activity is eligible for CPE credit through April 30, 2015. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates may be printed immediately after successfully completing the post-test and activity evaluation.

Faculty Biography

Jaroslaw P. Maciejewski, MD, PhD
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Chairman
Translational Hematology & Oncology Research
Taussig Cancer Institute
Cleveland, Ohio

Dr. Jaroslaw Maciejewski received his medical degree and doctorate from the Institute for Medical Immunology at Humboldt University Medical School, Berlin, Germany. He completed his internal medicine residency at the University of Nevada, School of Medicine, and hematology fellowship at the National Institutes of Health Medical Center. He also completed his postdoctoral research fellowship at the hematology branch of the National Heart, Lung and Blood Institute. Dr. Maciejewski is professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and is also chairman of the Department of Translational Hematology and Oncology Research at the Taussig Cancer Institute. In addition, he is a staff physician in the Cleveland Clinic Department of Hematologic Oncology and Blood Disorders.

Dr. Maciejewski is board certified in hematology and internal medicine. He serves on the Medical Advisory Board of the International Aplastic Anemia and Myelodysplastic Syndrome Foundation, the editorial board of Blood, has been a reviewer on various study sections for the NIH, and has written more than 150 peer-reviewed journal articles and book chapters. Recognized for his scholarly achievement in biomedical research, he is an elected member of The American Society for Clinical Investigation (ASCI). Dr. Maciejewski’s clinical areas of expertise include bone marrow failure syndromes and myeloid malignancies. His research deals with the molecular pathogenesis of these disorders and various specific aspects of stem cell biology, genetics, cytogenetics and immunobiology.

Accreditation

ACPE CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for .5 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-14-008-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.

Disclosure

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Jaroslaw Maciejewski has received honoraria related to speakers’ bureau activities from Celgene Corporation and Eisai Co., Ltd.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, and Eugene R. Tombler, PhD, FACME, medical director, oncology, have no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Dr. Maciejewski has indicated that he does intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Dr. Maciejewski has indicated that he does not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at info@managingmds.com.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.

©2014 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2017 MediCom Worldwide, Inc. All rights reserved